BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38485945)

  • 1. Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway.
    Li H; Liu Q; Hu Y; Yin C; Zhang Y; Gao P
    Cell Death Discov; 2024 Mar; 10(1):138. PubMed ID: 38485945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
    Yuan RX; Bao D; Zhang Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
    Fan S; Yan S; Yang Y; Shang J; Hao M
    Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA LINC00707, a prognostic marker, regulates cell proliferation, apoptosis, and EMT in esophageal squamous cell carcinoma.
    Gao N; Jiang G; Gao Z; Cui M; Li J; Liu H; Fan T
    Am J Transl Res; 2023; 15(4):2426-2442. PubMed ID: 37193148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
    Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
    Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Gao T; Ji Y
    Urol Int; 2021; 105(9-10):891-905. PubMed ID: 34192702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
    Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol Extract of
    Chen X; Li S; Li D; Li M; Su Z; Lai X; Zhou C; Chen S; Li S; Yang X; Su J; Zhang Y
    Front Pharmacol; 2020; 11():606. PubMed ID: 32411003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.
    Yang Y; Gao M; Lin Z; Chen L; Jin Y; Zhu G; Wang Y; Jin T
    Oncotarget; 2017 Nov; 8(58):98708-98722. PubMed ID: 29228721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.
    Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
    Li B; Huang L; Ruan J
    Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
    Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
    Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.